Outlook Therapeutics, Inc. (OTLK) Tops Q1 EPS by 1c

Outlook Therapeutics, Inc. (NASDAQ: OTLK) reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Outlook Therapeutics, Inc. (OTLK) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• H.B. Fuller (FUL) Tops Q3 EPS by 5c, Misses on Revenue; Offers FY26 EPS Guidance
• Interactive Strength reports record Q2 results, raises Q3 guidance